Umbilical Cord Blood Transplantation As Treatment Of Adult Patients With Hematologic Disorders
Status:
Completed
Trial end date:
2013-01-09
Target enrollment:
Participant gender:
Summary
To determine the time to and rate of hematologic engraftment following unrelated umbilical
cord blood transplantation in adults with one or two cord blood units using total body
irradiation and fludarabine as the transplant conditioning regimen and cyclosporine/MMF as
graft-versus-host disease prophylaxis.